Compounds > tenofovir
Page last updated: 2024-08-24

tenofovir and Aging

tenofovir has been researched along with Aging in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Cheung, AM; Clarke, R; De Pokomandy, A; Guaraldi, G; Lee, T; Messina, E; Singer, J; Smaill, F; Trottier, S; Walmsley, S1
Chetty, M; De Sousa Mendes, M1
Arnalich, F; Arribas, JR; Bernardino, JI; González-García, J; Martín-Carbonero, L; Mingorance, J; Monge, S; Montejano, R; Montes, ML; Moreno, V; Pérez-Valero, I; Perona, R; Pintado Berniches, L; Stella-Ascariz, N; Valencia, E1
Arendt, G; Orhan, E; Schlonies, S; Stüve, O1
Asin-Prieto, E; Derendorf, H; Samara, E; Sy, SK1
Cottrell, M; Dumond, JB; Forrest, A; Francis, O; Hudgens, MG; Malone, S; Mollan, K; Patterson, KB; Prince, HM; Sharpless, NE; Sykes, C; Torrice, C; Trezza, C; Van Dam, C; Wang, R; White, N1
Armishaw, J; Cameron, PU; Chuah, J; Cooper, DA; Crowe, SM; Fairley, C; Gouillou, M; Hearps, A; Koelsch, KK; Leeansyah, E; Lewin, SR; Liu, JP; Pierce, AB; Smit, de V; Solomon, A; Spelman, T; Tennakoon, S; Velayudham, P1
Antinori, A; Antonucci, F; Barreiro, P; Carosi, G; De Silvestri, A; El Hamad, I; Ladisa, N; Lapadula, G; Maggiolo, F; Mandalia, S; Maserati, R; Migliorino, G; Pierotti, P; Sighinolfi, L; Soriano, V; Suter, F; Torti, C1

Trials

1 trial(s) available for tenofovir and Aging

ArticleYear
BEING: Bone Health in Aging Women with HIV: Impact of Switching Antiretroviral Therapy on Bone Mineral Density During the Perimenopausal Period.
    AIDS research and human retroviruses, 2023, Volume: 39, Issue:4

    Topics: Adenine; Aging; Anti-HIV Agents; Bone Density; COVID-19; Female; HIV Infections; Humans; Middle Aged; Pandemics; Perimenopause; Tenofovir

2023

Other Studies

7 other study(ies) available for tenofovir and Aging

ArticleYear
Are Standard Doses of Renally-Excreted Antiretrovirals in Older Patients Appropriate: A PBPK Study Comparing Exposures in the Elderly Population With Those in Renal Impairment.
    Drugs in R&D, 2019, Volume: 19, Issue:4

    Topics: Adult; Aged; Aging; Anti-HIV Agents; Area Under Curve; Dose-Response Relationship, Drug; Emtricitabine; Humans; Kidney Diseases; Kidney Function Tests; Lamivudine; Middle Aged; Models, Biological; Predictive Value of Tests; Tenofovir; Young Adult

2019
Impact of Antiretroviral Treatment Containing Tenofovir Difumarate on the Telomere Length of Aviremic HIV-Infected Patients.
    Journal of acquired immune deficiency syndromes (1999), 2017, 09-01, Volume: 76, Issue:1

    Topics: Aging; Anti-HIV Agents; Cross-Sectional Studies; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Spain; Telomerase; Telomere; Tenofovir; Treatment Outcome; Viral Load

2017
Simplification of combination antiretroviral therapy (cART) and the brain-a real-life experience.
    Journal of neurovirology, 2019, Volume: 25, Issue:2

    Topics: Adult; Aging; Antiretroviral Therapy, Highly Active; Brain; Cognition; Cognitive Dysfunction; Emtricitabine; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Neuropsychological Tests; Quality of Life; Retrospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index; Tenofovir

2019
Predicting pediatric age-matched weight and body mass index.
    The AAPS journal, 2014, Volume: 16, Issue:6

    Topics: Adenine; Adolescent; Aging; Body Mass Index; Body Weight; Child; Child, Preschool; Computer Simulation; Female; Humans; Infant; Infant, Newborn; Male; Models, Biological; Models, Statistical; Organophosphonates; Predictive Value of Tests; Software; Tenofovir

2014
Tenofovir/emtricitabine metabolites and endogenous nucleotide exposures are associated with p16(INK4a) expression in subjects on combination therapy.
    Antiviral therapy, 2016, Volume: 21, Issue:5

    Topics: Adult; Aged; Aging; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclin-Dependent Kinase Inhibitor p16; Cyclopropanes; Drug Therapy, Combination; Emtricitabine; Female; Gene Expression; HIV Infections; Humans; Male; Middle Aged; Nucleotides; Ritonavir; Tenofovir; Young Adult

2016
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.
    The Journal of infectious diseases, 2013, Volume: 207, Issue:7

    Topics: Adenine; Adult; Aging; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cells, Cultured; Deoxycytidine; Dideoxynucleosides; Emtricitabine; Enzyme Activation; Female; HIV; HIV Infections; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Regression Analysis; Reverse Transcriptase Inhibitors; Risk Factors; Telomerase; Telomere; Telomere Shortening; Tenofovir; Time Factors; Young Adult; Zidovudine

2013
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:6

    Topics: Adenine; Adult; Aging; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Italy; Male; Middle Aged; Organophosphonates; Risk Factors; Sex Characteristics; Tenofovir; Treatment Outcome; Viral Load

2007